Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ghannoum

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Clinical Toxicology (Philadelphia, Pa.)|August 19, 2014
Extracorporeal treatment for acetaminophen poisoning: recommendations from the EXTRIP workgroupS Gosselin, D N Juurlink, J T Kielstein, et al.
Journal of Clinical Microbiology|January 1, 2016
Multilaboratory Evaluation of In Vitro Antifungal Susceptibility Testing of Dermatophytes for ME1111M Ghannoum, V Chaturvedi, D Diekema, et al.
Journal of Clinical Microbiology|October 7, 2005
Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M 38-A document) for amphotericin B, itraconazole, posaconazole, and voriconazoleA Espinel-Ingroff, A Fothergill, M Ghannoum, et al.
Antimicrobial Agents and Chemotherapy|May 17, 2001
Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp.: NCCLS collaborative evaluation. National Committee for Clinical Laboratory StandardsA Espinel-Ingroff, M Bartlett, V Chaturvedi, et al.
Journal of the American Academy of Dermatology|February 13, 2003
Tinea capitis in Cleveland: survey of elementary school studentsM Ghannoum, N Isham, R Hajjeh, et al.
Antimicrobial Agents and Chemotherapy|August 31, 2011
Wild-type MIC distributions and epidemiological cutoff values for amphotericin B and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document)A Espinel-Ingroff, M Cuenca-Estrella, A Fothergill, et al.
Journal of Clinical Microbiology|May 4, 2007
Quality control and reference guidelines for CLSI broth microdilution method (M38-A document) for susceptibility testing of anidulafungin against moldsA Espinel-Ingroff, A Fothergill, M Ghannoum, et al.
Journal of Clinical Microbiology|May 6, 2011
Quality control guidelines for amphotericin B, Itraconazole, posaconazole, and voriconazole disk diffusion susceptibility tests with nonsupplemented Mueller-Hinton Agar (CLSI M51-A document) for nondermatophyte Filamentous FungiA Espinel-Ingroff, E Canton, A Fothergill, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|July 15, 2009
The Oral HIV/AIDS Research Alliance: updated case definitions of oral disease endpointsC H Shiboski, L L Patton, J Y Webster-Cyriaque, et al.
Medical Mycology|February 13, 1999
Molecular mechanisms of virulence in fungus-host interactions for Aspergillus fumigatus and Candida albicansF Muhlschlegal, W Fonzi, L Hoyer, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Clinical Toxicology (Philadelphia, Pa.)|August 19, 2014
Extracorporeal treatment for acetaminophen poisoning: recommendations from the EXTRIP workgroupS Gosselin, D N Juurlink, J T Kielstein, et al.
Journal of Clinical Microbiology|January 1, 2016
Multilaboratory Evaluation of In Vitro Antifungal Susceptibility Testing of Dermatophytes for ME1111M Ghannoum, V Chaturvedi, D Diekema, et al.
Journal of Clinical Microbiology|October 7, 2005
Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M 38-A document) for amphotericin B, itraconazole, posaconazole, and voriconazoleA Espinel-Ingroff, A Fothergill, M Ghannoum, et al.
Antimicrobial Agents and Chemotherapy|May 17, 2001
Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp.: NCCLS collaborative evaluation. National Committee for Clinical Laboratory StandardsA Espinel-Ingroff, M Bartlett, V Chaturvedi, et al.
Journal of the American Academy of Dermatology|February 13, 2003
Tinea capitis in Cleveland: survey of elementary school studentsM Ghannoum, N Isham, R Hajjeh, et al.
Antimicrobial Agents and Chemotherapy|August 31, 2011
Wild-type MIC distributions and epidemiological cutoff values for amphotericin B and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document)A Espinel-Ingroff, M Cuenca-Estrella, A Fothergill, et al.
Journal of Clinical Microbiology|May 4, 2007
Quality control and reference guidelines for CLSI broth microdilution method (M38-A document) for susceptibility testing of anidulafungin against moldsA Espinel-Ingroff, A Fothergill, M Ghannoum, et al.
Journal of Clinical Microbiology|May 6, 2011
Quality control guidelines for amphotericin B, Itraconazole, posaconazole, and voriconazole disk diffusion susceptibility tests with nonsupplemented Mueller-Hinton Agar (CLSI M51-A document) for nondermatophyte Filamentous FungiA Espinel-Ingroff, E Canton, A Fothergill, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|July 15, 2009
The Oral HIV/AIDS Research Alliance: updated case definitions of oral disease endpointsC H Shiboski, L L Patton, J Y Webster-Cyriaque, et al.
Medical Mycology|February 13, 1999
Molecular mechanisms of virulence in fungus-host interactions for Aspergillus fumigatus and Candida albicansF Muhlschlegal, W Fonzi, L Hoyer, et al.
Pageof 5